9868 Federal Register / Vol. 66, No. 29 / Monday, February 12, 2001 / Notices

Media inquiries should be directed to

the HHS/OIG External Affairs Office,

330 Independence Avenue, SW.,

Washington, DC 20201. Requests for

written documentation should be

submitted in writing, together with a

printout from the OIG web site

identifying the individual or entity, to

the Office of Investigations, Health Care

Administrative Sanctions, Room N2–

01–26, 7500 Security Boulevard,

Baltimore, MD 21244–1850.

RECORD ACCESS PROCEDURE:

Same as notification procedure.

CONTESTING RECORD PROCEDURES:

An individual who wishes to contest

the record procedures should contact

the Office of Health Care Administrative

Sanctions, Office of Investigations,

Office of Inspector General, Department

of Health and Human Services, Room

N2–01–26, 7500 Security Boulevard,

Baltimore, MD 21244–1850. The

individual or entity should reasonably

identify the record and specify the

information to be contested, the

corrective action sought and the reasons

for the correction, with supporting

documentation.

RECORD SOURCE CATEGORIES:

The sources are Government and

private agencies and organizations.

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT:

None.

[FR Doc. 01–3419 Filed 2–9–01; 8:45 am]

BILLING CODE 4152–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Initial Review Group, Subcommittee

F—Manpower & Training.

Date: March 4–7, 2001.

Time: 6:30 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Georgetown, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Mary Bell, PhD., Scientific

Review Administrator, Grants Review

Branch, Division of Extramural Activities,

National Cancer Institute, National Institutes

of Health, PHS, DHHS, 6116 Executive

Boulevard, Room 8113, Bethesda, MD 20892–

8328, 301–496–7978.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower,; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: February 2, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3454 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel Small

Grants Program for Behavioral Research in

Cancer Control.

Date: March 1, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Ramada Inn, 1775 Rockville Pike,

Rockville, MD 20852.

Contact Person: Mary Jane Slesinski, PhD.,

Scientific Review Administrator, Special

Review and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8045, Bethesda,

MD 20892, 301/594–1566.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: February 2, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3455 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of meetings of the Board

of Scientific Counselors, National

Cancer Institute.

The meetings will be closed to the

public as indicated below in accordance

with the provisions set forth in section

552b(c)(6), Title 5 U.S.C., as amended

for the review, discussion, and

evaluation of individual intramural

programs and projects conducted by the

National Cancer Institute, including

consideration of personnel

qualifications and performance, and the

competence of individual investigators,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Board of Scientific

Counselors, National Cancer Institute

Subcommittee B—Basic Sciences.

Date: March 5, 2001.

Time: 12:15 p.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Cancer Institute, Building

31, C Wing, 6th Floor, Conference Rooms 6,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Florence E. Farber, PhD.,

Health Scientist Administrator, Institute

Review Office, Office of the Director,

National Cancer Institute, National Institutes

of Health, 6116 Executive Boulevard, Room

7017, Bethesda, MD 20892, 301/496–7628.

Name of Committee: Board of Scientific

Counselors, National Cancer Institute,

Subcommittee A—Clinical Sciences and

Epidemiology.